Literature DB >> 2071365

CSF oligoclonal banding pattern changes in a long-surviving SSPE patient treated with alpha-IFN.

L M Grimaldi1, G V Martino.   

Abstract

Oligoclonal bands are a constant, non-modifiable feature of CSF examination in SSPE. We studied CSF oligoclonal IgG banding pattern in a long-surviving SSPE patient treated with serial courses of intrathecal alpha-IFN. alpha-IFN administration did not significantly modify the clinical status of the patient. Oligoclonal IgG banding pattern varied during the 58 month-long treatment. Oligoclonal bands disappeared at the end of the first course only to reappear during the third course, 2 years later, with a different electrophoretic pattern. We conclude that oligoclonal bands may transiently disappear from the CSF of long-surviving SSPE patients. Although alpha-IFN treatment induces no clinical improvement, it might affect the quality of Ig production.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2071365     DOI: 10.1007/BF02337032

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  18 in total

Review 1.  Subacute sclerosing panencephalitis. Current status.

Authors:  P R Dyken
Journal:  Neurol Clin       Date:  1985-02       Impact factor: 3.806

2.  Interferon in treatment of subacute sclerosing panencephalitis.

Authors:  P O Behan
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

3.  Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis.

Authors:  D H Mattson; R P Roos; B G Arnason
Journal:  Ann Neurol       Date:  1981-01       Impact factor: 10.422

Review 4.  Rapid evolution of RNA genomes.

Authors:  J Holland; K Spindler; F Horodyski; E Grabau; S Nichol; S VandePol
Journal:  Science       Date:  1982-03-26       Impact factor: 47.728

5.  Long-term intramuscular recombinant DNA interferon alpha 2 therapy in subacute sclerosing panencephalitis: reduction of serum measles antibodies without clinical improvement.

Authors:  R Crols; A Lowenthal
Journal:  Eur Neurol       Date:  1987       Impact factor: 1.710

6.  Defective translation of measles virus matrix protein in a subacute sclerosing panencephalitis cell line.

Authors:  M J Carter; M M Willcocks; V ter Meulen
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

7.  Silver staining of cerebrospinal fluid IgG in isoelectric focusing gels.

Authors:  R P Roos; M Lichter
Journal:  J Neurosci Methods       Date:  1983-08       Impact factor: 2.390

8.  Rapid degradation restricts measles virus matrix protein expression in a subacute sclerosing panencephalitis cell line.

Authors:  R D Sheppard; C S Raine; M B Bornstein; S A Udem
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

9.  Intrathecal interferon in subacute sclerosing panencephalitis.

Authors:  D Maimone; L M Grimaldi; G Incorpora; R Biondi; V Sofia; G R Mancuso; L Siciliano; M Ruscica; L Pavone
Journal:  Acta Neurol Scand       Date:  1988-09       Impact factor: 3.209

10.  Subacute sclerosing panencephalitis: remission after treatment with intraventricular interferon.

Authors:  H S Panitch; J Gomez-Plascencia; F H Norris; K Cantell; R A Smith
Journal:  Neurology       Date:  1986-04       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.